Alnylam Pharmaceuticals
ALNY
#575
Rank
C$50.82 B
Marketcap
$394.05
Share price
-2.11%
Change (1 day)
68.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company